New Key Statistics Module, Z-Score and F-Score
NYSE:GMED Key Ratios
Market Cap $ M | 9,733.06 |
Enterprise Value $ M | 9,792.45 |
P/E(ttm) | 239.60 |
PE Ratio without NRI | 43.54 |
Forward PE Ratio | 25.19 |
Price/Book | 2.45 |
Price/Sales | 4.27 |
Price/Free Cash Flow | 59.32 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,236.00 |
EPS (TTM) $ | 0.30 |
Beneish M-Score | -1.64 |
10-y EBITDA Growth Rate % | 6.60 |
5-y EBITDA Growth Rate % | 8.60 |
y-y EBITDA Growth Rate % | -3.70 |
EV-to-EBIT | 58.10 |
EV-to-EBITDA | 24.73 |
PEG | 5.06 |
Shares Outstanding M | 135.41 |
Net Margin (%) | 1.82 |
Operating Margin % | 7.54 |
Pre-tax Margin (%) | 2.98 |
Quick Ratio | 1.45 |
Current Ratio | 2.42 |
ROA % (ttm) | 0.90 |
ROE % (ttm) | 1.13 |
ROIC % (ttm) | 2.68 |
Dividend Yield % | -- |
Altman Z-Score | 6.82 |
GMED Number of Guru Trades
GMED Volume of Guru Trades
Gurus Latest Trades with NYSE:GMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:GMED is held by these investors
Total 2
Globus Medical Inc Insider Transactions
No Available Data
News about NYSE:GMED
Total 0- 1